Home » Anna Du

Anna Du

Senior Analyst

Anna Du is a Senior Analyst at CBPartners.

Connect with Anna Du

anna.du@cbpartners.com

LinkedIn

Published Articles

Clinical Trial Disruptions: Can Small-Cap Biopharma Companies Weather the Impact of COVID-19?

Cumulative costs from patient enrollment scenarios due to COVID-19 will likely generate a significant financial drain on biopharma R&D expenditures. CBPartners' blog post investigates this impact and explores mitigation strategies.